Basal cell carcinoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Basal cell carcinoma}} | |||
==Overview== | |||
==Basal Cell Carcinoma Medical Therapy== | |||
After the suspicious lesion is evaluated, the medical therapy is divided into low-risk and high-risk basal carcinoma patients. | |||
The table below summarizes the characteristics in low-risk and high-risk lesions<ref>http://www.nccn.org/professionals/physician_gls/PDF/nmsc.pdf</ref>. | |||
{| {{table}} | |||
| align="center" style="background:#f0f0f0;"|'''H&P''' | |||
| align="center" style="background:#f0f0f0;"|'''Low Risk''' | |||
| align="center" style="background:#f0f0f0;"|'''High Risk''' | |||
|- | |||
| '''Location/size'''||Area L <20 mm; Area M <10 mm; Area H <6 mm||Area L ≥20 mm; Area M ≥10 mm; Area H ≥6 mm | |||
|- | |||
| '''Borders'''||Well defined||Poorly defined | |||
|- | |||
| '''Primary vs. recurrent'''||Primary||Recurrent | |||
|- | |||
| '''Immunosuppression'''||(-)||(+) | |||
|- | |||
| '''Site of prior radiation therapy'''||(-)||(+) | |||
|- | |||
| '''Subtype'''||Nodular, superficial||Aggressive growth pattern | |||
|- | |||
| '''Perineural involvement'''||(-)||(+) | |||
|} | |||
The algorithm below demonstrates a treatment protocol for '''low-risk''' patients that can tolerate surgery <ref>http://www.nccn.org/patients/guidelines/nscl/#56/z</ref>. | |||
[[Image:Stage I.jpg|800px]] | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
Revision as of 18:24, 23 July 2015
|
Basal cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Case Studies |
|
Basal cell carcinoma medical therapy On the Web |
|
American Roentgen Ray Society Images of Basal cell carcinoma medical therapy |
|
Risk calculators and risk factors for Basal cell carcinoma medical therapy |
Overview
Basal Cell Carcinoma Medical Therapy
After the suspicious lesion is evaluated, the medical therapy is divided into low-risk and high-risk basal carcinoma patients.
The table below summarizes the characteristics in low-risk and high-risk lesions[1].
| H&P | Low Risk | High Risk |
| Location/size | Area L <20 mm; Area M <10 mm; Area H <6 mm | Area L ≥20 mm; Area M ≥10 mm; Area H ≥6 mm |
| Borders | Well defined | Poorly defined |
| Primary vs. recurrent | Primary | Recurrent |
| Immunosuppression | (-) | (+) |
| Site of prior radiation therapy | (-) | (+) |
| Subtype | Nodular, superficial | Aggressive growth pattern |
| Perineural involvement | (-) | (+) |
The algorithm below demonstrates a treatment protocol for low-risk patients that can tolerate surgery [2].
